Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HHS Message On Value-Based Drug Pricing Complicated But Themes Emerging

Nov 07 2018

• By Cathy Kelly

Low value

Related Content

CMS' Verma Touts Value-Based Payments After Cancellation Of Pilot For Novartis' Kymriah

Jul 13 2018

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

Oklahoma Medicaid Plan For Value-Based Contracts Cleared By CMS

Jun 27 2018

Related Companies

Novartis AG

Additional Topics

United States Pricing Debate Government Payers Reimbursement Policy Medicaid Market Access BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.